Resource Library

Assessments

Clinical Opiate Withdrawal Scale (COWS)

This tool can be used in both inpatient and outpatient settings to reproducibly rate common signs and symptoms of opiate withdrawal and monitor these symptoms over time.

View the resource

Diagnosis, Intractability, Risk and Efficacy (DIRE)

DIRE Score: Patient Selection for Chronic Opioid Analgesia

View the resource

NIDA Quick Screen V1.0

Details the NIDA Quick Screen with a reflex to NIDA-Modified ASSIST.

View the resource

Opioid Risk Tool (ORT)

The Opioid Risk Tool (ORT) is a brief, self-report screening tool designed for use with adult patients in primary care settings to assess risk for opioid abuse among individuals prescribed opioids for treatment of chronic pain.

View the resource

PEG13: A Three-Item Scale Assessing Pain

Development and Initial Validation of the PEG, a Three-item Scale Assessing Pain Intensity and Interference

View the resource

Validation of a Brief Measure of Opioid Dependence: The Rapid Opioid Dependence Screen (RODS)

This study reports on the initial validation of the RODS among a sample of 97 newly incarcerated, HIV-positive individuals.

View the resource

General

Addiction Center’s Glossary of Drug Street Names

Use this glossary to see the brand, generic, and street names of various drugs.

View the resource

CDC HIV Surveillance Special Report: HIV Infection Risk, Prevention, and Testing Behaviors Among Persons Who Inject Drugs

This CDC infographic details findings from National Behavioral Surveillance on behaviors of people who inject drugs in relation to HIV risk, prevention, and testing.

Download the resource

COVID-19 Pandemic Provides Opportunity To Realign Self-Help Groups With Medications For People With Opioid Use Disorder

In this month’s issue of Health Affairs, Hefei Wen and coauthors analyze national data on opioid addiction treatment. In response to world events, we asked the authors to put their work in the context of the current COVID-19 crisis.

View the resource

Incorporating Opioid Use Disorder Screening and Treatment into HIV and HCV Management

View this slide deck to gain insights on the critical role ID specialists and hepatologists can play in addressing the ongoing opioid use disorder (OUD) epidemic and learn practical strategies for incorporating OUD screening, patient evaluation, and treatment into HIV and HCV care settings.

View the resource

Needle Exchange in DC

Providers and locations in the District of Columbia that provide needle exchange and harm reduction services

View the resource

NIH National Institute on Drug Abuse – Opioids

Opioids are a class of drugs that include the illegal drug heroin, synthetic opioids such as fentanyl, and pain relievers available legally by prescription.

View the resource

Opioid Awareness Campaign and Education

Opioid awareness and education in the DC metro area.

View the resource

Opioid death rates soared in communities where pain pills flowed

Death rates from opioids soared in the towns, cities and counties that were saturated with billions of prescription pain pills from 2006 through 2012, according to government death data and a previously undisclosed database of opioid shipments.

View the resource

Suicide, opioids tied to ongoing fall in US life expectancy: Third year of drop

American life expectancy continues to decline, with high mortality rates largely fueled by suicide and drug overdoses — both growing public health crises that reflect deficiencies across many social determinants of health.

View the resource

Understanding the Opioid Overdose Epidemic

Drug overdose deaths continue to increase in the United States. Learn more about the opioid overdose epidemic.

View the resource

Harm Reduction

COVID-19 Harm Reduction Toolkit

The COVID-19 Harm Reduction Toolkit, created by Higher Ground Harm Reduction, Reynolds Health Strategies and global health organization Vital Strategies, provides informative fact sheets, tips and guidance for people who use drugs, engage in sex work, those who are unhoused, and the stakeholders who work with these communities.

View the resource

How to Get Rid of a Sharps Container

Safe Disposal of Needles and Other Sharps Used At Home, At Work, or While Traveling

View the resource

U.S. Food and Drug Administration Safe Opioid Disposal – Remove the Risk Outreach Toolkit

Remove the Risk Toolkit raises awareness of the serious dangers of keeping unused opioid pain medication in the home and provides information about safe disposal of these medicines.

View the resource

Van Asher’s Fentanyl Test Strip Video

Informative video on the correct way to use test strips to detect Fentanyl in drugs.

View the resource

MAT

Buprenorphine Practitioner Locator

Find practitioners authorized to treat opioid dependency with buprenorphine by state.

View the resource

Free MAT Trainings for Prescribers

The overarching goal of PCSS is to provide the most effective evidenced-based clinical practices in the prevention of OUD through proper opioid prescribing practices, identifying patients with OUD, and the treatment of opioid use disorder.

View the resource

Medication-Assisted Treatment (MAT) for Opioid Use Disorder in Jails and Prisons: A Planning and Implementation Toolkit

To reduce risk of opioid overdose and recidivism and to better serve incarcerated individuals with opioid use disorder, the National Council, in partnership with Vital Strategies and faculty from Johns Hopkins University, developed a new resource guide titled: Medication-Assisted Treatment for Opioid Use Disorder in Jails and Prisons: A Planning and Implementation Toolkit.

View the resource

PCSS Overview of Medications for Addiction Treatment

Medications for Addiction Treatment (MAT) of Substance Use Disorders involves a combination of a medications that targets the brain, and psychosocial interventions (e.g., counseling, skills development) aimed at improving treatment outcomes. Research shows that medications and therapy together may be more successful than either treatment method alone. Learn more about MAT Waiver Training!

View the resource

Provider’s Clinical Support System for Medication-Assisted Treatment

PCSS is a program funded by the Substance Abuse and Mental Health Services Administration (SAMHSA) created in response to the opioid overdose epidemic to train primary care providers in the evidence-based prevention and treatment of opioid use disorders (OUD) and treatment of chronic pain.

View the resource

SAMHSA’s Medication-Assisted Treatment for Substance Use Disorders Opioid Treatment Program Directory

Select a state and find all of the contact information of the opioid treatment centers located within the selected state.

View the resource

The ASAM Treatment of Opioid Use Disorder Course

The ASAM Treatment of Opioid Use Disorder (TOUD) Course covers all medications and treatments for opioid use disorder, and provides the required education needed to obtain the waiver to prescribe buprenorphine. ASAM is an approved provider by CSAT/SAMHSA of DATA 2000 training.

View the resource

The Curbsiders Podcast #187 Buprenorphine Master Class: Managing Opioid Use Disorder for the Generalist

Get comfortable with counseling and pharmacotherapy for OUD with tips from Dr. Michael Fingerhood (Johns Hopkins).  We review building a therapeutic relationship with people with substance use disorders, the differences between the three FDA-approved medications for opioid use disorder, and the nitty-gritty of prescribing buprenorphine.

View the resource

Overdose Prevention

Get Naloxone — Opioid Learning Institute Naloxone Education

Share this video with your Social Networks!

View the resource

Share this:
f l p m

Local Opioid Prevention and Response: A Primer for Local Health Departments

Create a free account and download the link on the right side of page. Local Opioid Prevention and Response: A Primer for Local Health Departments serves to inform local health departments about the domestic opioid epidemic and share success stories from LHDs currently engaged in opioid-related efforts.

View the resource

Offering Naloxone to Patients

Here you will find information you need to start prescribing and dispensing naloxone rescue kits, including some useful resources containing further information about this life-saving medicine.

View the resource

U.S. Preventive Services Task Force: Screening for Unhealthy Drug Use

The U.S. Preventive Services Task Force released a final recommendation statement on screening for unhealthy drug use. That Task Force found that clinicians should ask adults about their drug use and connect people who have a problem to care.

View the resource

Pain Management

Kaiser Permanente’s Proactive Approach to Opioid Management

A proactive, proven approach to addressing the opioid epidemic

View the resource

Project Lazarus and Community of Care North Carolina Pain Management Toolkits

Project Lazarus and Community Care of North Carolina developed the Chronic Pain Initiative toolkits below to provide best practices and protocol for Primary Care Providers and Emergency Departments

View the resource

Sample Patient Agreement Form

This resource includes two sample patient agreement forms that can be used with patients who are beginning long-term treatment with opioid analgesics or other controlled substances.

View the resource

Prescribing Guidelines

2019 Recommendations of the AMA Opioid Task Force

AMA Opioid Task Force issues new recommendations to urge policymakers to protect patients' access to evidence-based treatment and remove barriers to comprehensive pain care

View the resource

CDC Guidelines at a Glance

CDC guideline for prescribing opioids for chronic pain.

View the resource

CDC Opioid Prescribing Guidelines

This guideline provides recommendations for primary care clinicians who are prescribing opioids for chronic pain outside of active cancer treatment, palliative care, and end-of-life care.

View the resource

FDA issues warning for products marketed to treat opioid withdrawal

The FDA sent a warning letter to EPH Technologies, accusing it of marketing and selling unapproved drugs.

View the resource

Framing Opioid Prescribing Guidelines for Acute Pain: Developing the Evidence

This report recommends two frameworks—an analytic framework and an evidence evaluation framework—that medical professional societies, health care organizations, and state, national, and local agencies could use to develop CPGs for prescribing opioids to manage acute pain.

View the resource

Minnesota Opioid Prescribing Guidelines, First Edition 2018

This is the first edition of the Minnesota Opioid Prescribing Guidelines.

View the resource

The ASAM National Practice Guideline for the Treatment of Opioid Use Disorder – 2020 Focused Update

The ASAM National Practice Guideline 2020 focused update is intended to inform and empower clinicians, health system administrators, criminal justice system administrators, and policymakers who are interested in implementing evidence-based practices to improve outcomes for individuals with OUD. This is especially critical in the context of the ongoing COVID-19 emergency, which threatens to curtail patient access to evidence-based treatment.

View the resource

The COVID-19 Pandemic: Practice and Policy Considerations For Patients with Opioid Use Disorder

This article details US policy updates that are loosening restrictions around MOUD prescribing in light of COVID-19.

View the resource

Tapering

CDC Pocket Guide: Tapering Opioids for Chronic Pain

Follow up regularly with patients to determine whether opioids are meeting treatment goals and whether opioids can be reduced to lower dosage or discontinued.

View the resource

HHS Guide for Clinicians on the Appropriate Dosage Reduction or Discontinuation of Long-Term Opioid Analgesics

HHS's guide on dosage reduction, tapering, or discontinuation of long term opioid analgesics.

View the resource

Treatment

American Society of Addiction Medicine: Appropriate Use of Drug Testing in Clinical Addiction Medicine

This resource provides guidance about the effective use of drug testing in the identification, diagnosis, treatment, and promotion of recovery for patients with, or at risk for, addiction.

View the resource

Clinical Mentoring for Treating OUD

The overarching goal of PCSS is to provide the most effective evidenced-based clinical practices in the prevention of OUD through proper opioid prescribing practices, identifying patients with OUD, and the treatment of opioid use disorder.

View the resource

Essentials of Opioid Use Disorder: A Resource for Hepatologists and Infectious Disease Specialists Managing HCV and/or HIV Infection

Download this PDF guide outlining key information on identifying and treating opioid use disorder among patients with HIV and or HCV infection.

View the resource

Motivational Interviewing (MI) Resources and Webinars

Motivational Interviewing is a clinical approach that helps people with mental health, substance use disorders and other chronic conditions.

View the resource

PCSS Resources for Health Professionals, Patients and Community

These resources for treating OUD and chronic pain were developed for health professionals, patients, family members and significant others of patients and the general community to learn more about the evidence-based treatment of opioid use disorders and the treatment of chronic pain.

View the resource

The ASAM National Practice Guideline for the Treatment of Opioid Use Disorder – 2020 Focused Update

The ASAM National Practice Guideline 2020 focused update is intended to inform and empower clinicians, health system administrators, criminal justice system administrators, and policymakers who are interested in implementing evidence-based practices to improve outcomes for individuals with OUD.

View the resource

The Opioid Crisis and the Black/African American Population: An Urgent Issue

This issue brief presents recent data on prevalence of opioid misuse and death rates in the Black/AA population; contextual factors & challenges to prevention & treatment; innovative outreach & engagement strategies to connect people to evidence-based treatment; and the importance of community voice.

View the resource

TIP 63: Medications for Opioid Use Disorder – Full Document

This Treatment Improvement Protocol (TIP) reviews the use of the three Food and Drug Administration (FDA)-approved medications used to treat OUD—methadone, naltrexone, and buprenorphine—and the other strategies and services needed to support recovery for people with OUD.

View the resource